Nocardia: Difference between revisions
From IDWiki
Nocardia
m (Text replacement - "[[Cellular shape::" to "[[Shape::") |
No edit summary |
||
| Line 11: | Line 11: | ||
*Mild to moderate: [[Is treated by::TMP-SMX]] |
*Mild to moderate: [[Is treated by::TMP-SMX]] |
||
**Immunocompetent: 5-10 mg/kg split tid to qid |
|||
**Immunocompromised: 15 mg/kg split tid to qid |
|||
*Severe: [[Is treated by::TMP-SMX]] plus either [[Is treated by::amikacin]] or [[Is treated by::imipenem]] |
*Severe: [[Is treated by::TMP-SMX]] plus either [[Is treated by::amikacin]] or [[Is treated by::imipenem]] |
||
*Other antimicrobials include [[Is treated by::ceftriaxone]], [[Is treated by::minocycline]], and [[Is treated by:: linezolid]] |
*Other antimicrobials include [[Is treated by::ceftriaxone]], [[Is treated by::minocycline]], and [[Is treated by:: linezolid]] |
||
Revision as of 17:53, 9 September 2021
Background
Microbiology
- Beaded Gram-positive partially acid-fast bacillus
Management
- Mild to moderate: TMP-SMX
- Immunocompetent: 5-10 mg/kg split tid to qid
- Immunocompromised: 15 mg/kg split tid to qid
- Severe: TMP-SMX plus either amikacin or imipenem
- Other antimicrobials include ceftriaxone, minocycline, and linezolid
